

Advanced Parenteral Closure Solutions, The Perfect Fit Towards Compliance With EMA GMP Annex 1 Revision
Wednesday, January 24, 2024 9:50 AM to 10:20 AM · 30 min. (Africa/Abidjan)
Learning Lab Theatre L20
Learning Labs
Information
The revision of the European Medical Agency annex 1 of the GMP poses new challenges for Pharma manufacturers who have to implement a contamination control and sterility assurance strategies. Aptar Pharma Injectables’ Advanced Solutions perfectly combine to support our Pharma partners in tackling these new stringent requirements:
- PremiumFill®: Enhanced manufacturing means designed to deliver higher quality products with improved specifications, especially on contamination criteria, to boost your Contamination Control Strategy
- RTP bags: the new standard for avoiding contamination on aseptic filling lines, highly recommended in the Annex 1 revision.
- Ready-to-Use Gamma: the only 100% guarantee of sterility at the time of use as requested in the Annex 1 revision.
